Topic: Pay for delay

Wright: Rulemaking could be next IP/antitrust battleground

The US antitrust agencies’ losses in intellectual property cases have increased the likelihood of a competition rulemaking, according to former Federal Trade Commission member Joshua Wright.

01 September 2020

Ninth Circuit judge questions generic drugmakers on imminent harm

Judge Andrew Hurwitz of the US Court of Appeals for the Ninth Circuit has asked generic drugmakers why they need to block a California law restricting pay-for-delay settlements if they do not plan to enter into such agreements.

17 July 2020

Fifth Circuit ponders patent settlement incentives in Impax appeal

The US Court of Appeals for the Fifth Circuit has questioned Impax Laboratories and the Federal Trade Commission on what can be legally conceded in settling patent litigation.

10 June 2020

Niaspan buyers denied class cert

A federal judge in Pennsylvania has rejected a bid for class certification by end-purchasers of cholesterol medication Niaspan in their lawsuit against drugmakers AbbVie and Teva Pharmaceuticals.

05 June 2020

Unlock unlimited access to all Global Competition Review content